Showing results (161-170 of 290) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancerVincent A Miller, Mark G Kris, Neelam Shah, et al.
Oncotarget|May 24, 2016
Relationship of smoking status to genomic profile, chemotherapy response and clinical outcome in patients with advanced urothelial carcinomaMonika Joshi, Monali Vasekar, Petros Grivas, et al.
Gastroenterology|April 12, 2016
Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel DiseaseRona Yaeger, Manish A Shah, Vincent A Miller, et al.
The Oncologist|March 12, 2017
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A AlterationJulia A Elvin, Laurie M Gay, Rita Ort, et al.
Cancer|June 6, 2017
Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapySiraj M Ali, Ming Yao, Jicheng Yao, et al.
The Annals of Thoracic Surgery|October 30, 2004
SCCRO expression correlates with invasive progression in bronchioloalveolar carcinomaInderpal S Sarkaria, DuyKhanh Pham, Ronald A Ghossein, et al.
Cancer|June 11, 2016
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapiesJeffrey S Ross, Laurie M Gay, Kai Wang, et al.
The Oncologist|August 16, 2018
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation BurdenWinnie S Liang, Jo-Anne Vergilio, Bodour Salhia, et al.
Human Pathology|October 29, 2017
General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling studyHwajeong Lee, Tony El Jabbour, Sanaz Ainechi, et al.
Cancer Chemotherapy and Pharmacology|August 10, 2006
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumorsMatthew G Fury, David B Solit, Yungpo Bernard Su, et al.
Pageof 29